Highlights Eastgate Biotech Corp.

Equities

ETBI

US2772531008

Market Closed - OTC Markets Other stock markets 14:54:04 30/04/2024 BST			5-day change	1st Jan Change
0.009 ^USD	+28.57%		-.--%	-10.00%

2021	EastGate Biotech Corp., Dr. Upadhyay Vedic Research Laboratories and ImmunoJuvenate, Inc. Enter Into a 3-way International Distribution Agreement	CI
2021	EastGate Biotech Corp. Enters into A Licensing and Distribution Agreement for Glucora	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EastGate Biotech Corp., Dr. Upadhyay Vedic Research Laboratories and ImmunoJuvenate, Inc. Enter Into a 3-way International Distribution Agreement	17/05/21	CI
EastGate Biotech Corp. Enters into A Licensing and Distribution Agreement for Glucora	08/03/21	CI
EastGate Biotech Corp. and EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19	18/02/20	CI
Eastgate Biotech Corp. Announces Phase 3 Clinical Trials of Insurgin	05/02/20	CI
EastGate Biotech Corp. Partners with EastGate Biotech Pakistan for the International Marketing Rights of Anaferon	30/01/20	CI
EastGate Biotech Corp Expands Pipeline to Alzheimer’S Disease Using Its Alternative Insulin Delivery Platform	14/11/19	CI
Eastgate Biotech Corp. Announces Expansion and Restructuring of Joint Venture with Its Partner in Pakistan	09/10/19	CI
EastGate Biotech Receives Regulatory Approval to Initiate a Phase III 90-day Clinical Trial on Insugin, Its Liquid Insulin Mouth Rinse Solution	25/09/19	CI
EastGate Biotech Corp Announces It Has Filed an Application with the Drug Regulatory Authority of Pakistan and Ministry of National Health Services to Initiate A Phase Iii Clinical Study for Insugin	26/06/19	CI
Eastgate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin	15/05/19	CI
EastGate Biotech Announces Positive Phase II Clinical Results of its Innovative Liquid Insulin Mouth Rinse Solution for Type 2 Diabetes	24/04/19	CI
Eastgate Biotech Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2017	04/03/19	CI
EastGate Biotech Enters into Licensing Agreement with Nico Innovapharma	28/08/18	CI
EastGate Biotech Corp. Enters into a Memorandum of Understanding with Genluiching Mining Corporation and AAH International Associates Inc	18/03/18	CI
Eastgate Biotech Corp. Enters into Joint Venture with AC Nova Technologies Inc	04/04/17	CI
Eastgate Biotech Corp. entered into a purchase and sale agreement to acquire OMNI Surgery + Anti-Aging Centre from Bill Abajian.	13/03/17	CI
EastGate Biotech Corp. Receives Large Order for Glucora, its Natural Glucose Management Product	05/05/16	CI
EastGate Biotech Corp. Receives Repeat Purchase Order from Preferred Nutrition Inc	06/01/16	CI
Eastgate Biotech Corp. Announces Commencement of Activities for its Proprietary Intraoral Insulin Tablet	29/09/15	CI
EastGate Biotech Receives Purchase Order from Its Canadian Distributor for Nutraceutical Products	11/03/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Eastgate Biotech Corp.

Equities

ETBI

US2772531008

Highlights

Filters